Our Private Equity Partners
WCCT is fortunate to be backed by two private equity groups with more than $1.4 billion in capital under management.
Founded in 2012, Medivate is one of the first private equity firms in Korea with the expertise in value investing cross-border life sciences industry. Medivate has raised ~$100 million capital into 5 portfolio companies which include clinical stage biotech companies and contract development manufacturing organizations (CDMOs). Medivate’s management team has a proven record in the life sciences industry and provides competitive advantage by leveraging strategic partnership with the portfolio companies, a key to successful investment returns.
Housatonic Partners is a private equity investment firm founded in 1994, with more than $1.3 billion in capital under management. The firm invests in growing, profitable businesses with highly recurring revenue. Housatonic Partners has backed exceptional management teams in more than 90 small to mid-sized companies over the last 25 years.